Avalo Therapeutics Inc (AVTX) — Cash Flow Reinvestment Rate
Avalo Therapeutics Inc (AVTX) has a Cash Flow Reinvestment Rate of 0.01x as of September 2022, reinvesting $78.00K (capex $39.00K plus investments $-39.00K) from operating cash flow of $5.73 Million. See AVTX free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Avalo Therapeutics Inc Cash Flow Reinvestment Rate (2017–2017)
Historical reinvestment intensity for Avalo Therapeutics Inc across 1 annual periods. For the full cash flow conversion analysis, see Avalo Therapeutics Inc cash conversion from operations.
Annual Cash Flow Reinvestment Rate for Avalo Therapeutics Inc (2017–2017)
Year-by-year capital reinvestment analysis for Avalo Therapeutics Inc. See AVTX free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2017 | 1.03x | $12.86 Million | $12.52 Million | $23.32K | — |